Clinical Trial Update: Baclofen to Reduce Alcohol Use in Veterans With HCV [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating baclofen to reduce alcohol use in veterans with hepatitis C; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Hepatitis C

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Hepatitis C, Alcohol Use Disorders | Phase 4 | Status: COMPLETED | Results posted: 2015-06-09